<ѻý>Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonistsѻý> Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
<ѻý>Type D Personality and Hypothyroidism; Infertility and eGFR; Fracture Algorithmѻý> News and commentary from the endocrinology world Apr 09, 2024
<ѻý>Chelation Flops for Cardio Health After Heart Attackѻý> TACT2 trial fails to confirm benefits in subgroup that gained the most in initial trial Apr 08, 2024
<ѻý>Wegovy Helps HFpEF Patients With Diabetes Mellitusѻý> Weight and symptoms improved in STEP-HFpEF DM trial Apr 07, 2024
<ѻý>Specialty Care Access Not Equal Among Teens With Diabetesѻý> Claims for specialists significantly lower for youth with type 2 versus type 1 diabetes Apr 05, 2024
<ѻý>Primary Care Strategy Fails to Reduce Kidney-Dysfunction Triad Hospitalizationsѻý> Secondary outcomes also showed no significant differences Apr 03, 2024
<ѻý>Diabetes Drug Shows Benefit in Parkinson's Diseaseѻý> Phase II study of GLP-1 drug lixisenatide meets primary endpoint Apr 03, 2024
<ѻý>Weight-Loss Drug Zepbound Faces Supply Issuesѻý> Following weight-loss indication, patients struggle to obtain tirzepatide Apr 02, 2024
<ѻý>Diabetes Drugs Overpriced; Hormone Drugs and Brain Tumors; Menopause or Herpes?ѻý> News and commentary from the endocrinology world Apr 02, 2024
<ѻý>GLP-1 Users May Have Increased Endoscopy-Related Aspiration Pneumonia Riskѻý> Overall incidence is still low, however Apr 01, 2024
<ѻý>When Medicalization Goes Too Farѻý> The boundaries between health and disease often get a little blurry Mar 31, 2024
<ѻý>Here's What OTC Continuous Glucose Monitors Can Do for Our Patientsѻý> FDA's approval may be a step toward greater access Mar 30, 2024
<ѻý>Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It?ѻý> News and commentary from the endocrinology world Mar 26, 2024
<ѻý>Out-of-Pocket Insulin Caps Boost Savings -- But Not Insulin Useѻý> Proposed national $35 insulin cap would help some patients, researchers say Mar 25, 2024
<ѻý>Automated Insulin System OK'd; Zepbound Gains in Popularity; Male Menopause Cures?ѻý> News and commentary from the endocrinology world Mar 19, 2024
<ѻý>Is SGLT2 Inhibitor-Associated Ketoacidosis Treated With Enough Insulin?ѻý> Study suggests these patients receive significantly lower doses vs those with T1D ketoacidosis Mar 18, 2024
<ѻý>Slowing of Peripheral Artery Disease: Another Liraglutide Benefit?ѻý> GLP-1 receptor agonist significantly slowed progression over 6 months Mar 13, 2024
<ѻý>Novel Drug Better Than Wegovy? New Endocrine Society Prez; Knockoff Tirzepatide Woesѻý> News and commentary from the endocrinology world Mar 12, 2024
<ѻý>Deaths Due to Alcohol Use; Steps for the Sedentaryѻý> Also in TTHealthWatch: microplastics in arteries, and worldwide obesity and diabetes risk Mar 09, 2024 podcast
<ѻý>Cardiometabolic Disorders Tend to Accompany a 'Lazy Eye'ѻý> Persistent amblyopia associated with myocardial infarction and death Mar 08, 2024
<ѻý>One-Week GLP-1 Agonist Hold Not Enough Before Anesthesia?ѻý> Even following this rule, increased residual gastric content still prevalent Mar 07, 2024
<ѻý>FDA Clears First OTC Continuous Glucose Monitorѻý> Dexcom's Stelo system available without a prescription by the summer Mar 06, 2024
<ѻý>Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1Dѻý> News and commentary from the endocrinology world Mar 05, 2024
<ѻý>FDA Says Eating Yogurt May Reduce Diabetes Riskѻý> Products will be allowed to carry claims as long as they don't mislead consumers Mar 04, 2024
<ѻý>Bariatric Surgery a Long-Term Winner for Type 2 Diabetesѻý> Clinical trials show advantages over lifestyle, medication out to 12 years Feb 27, 2024
<ѻý>FDA: Don't Use Smartwatches, Smart Rings for Blood Glucose Measurementsѻý> Noninvasive devices that don't pierce the skin can give inaccurate measurements Feb 22, 2024
<ѻý>T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicalsѻý> News and commentary from the endocrinology world Feb 20, 2024
<ѻý>States Target Health Insurers' Red Tape Around Prior Authorizationѻý> Pending bills in multiple states include policies backed by the AMA Feb 19, 2024
<ѻý>SGLT2 Inhibitors Tied to Better NAFLD Outcomes vs Other Antidiabetic Agentsѻý> Class of drug associated with highest odds of NAFLD regression for patients with type 2 diabetes Feb 14, 2024
<ѻý>Denosumab Protective Against Diabetes?ѻý> Study found lower diabetes incidence with osteoporosis drug for patients who stayed on treatment Feb 13, 2024
<ѻý>Rapid Weight Loss a Diabetic Retinopathy Risk?ѻý> While research is conflicting, GLP-1 therapies might cause transient worsening of retinal disease Feb 12, 2024
<ѻý>Can a Common Diabetes Drug Turn Patients' Urine Into Alcohol?ѻý> Case study highlights importance of proper urine sample storage Feb 07, 2024
<ѻý>More Mounjaro Doses Limited; At-Home Menopause Tests? Kimchi for Lower Obesity Riskѻý> News and commentary from the endocrinology world Feb 06, 2024
<ѻý>Durable Weight Loss Follows Just a Few Injections of Novel Drugѻý> Most of the body weight reduction persisted 150 days after the last dose in an early-phase trial Feb 05, 2024
<ѻý>Health Effects of Diabetes Remission; High-Deductible Plans for Cancer Patientsѻý> Also in TTHealthWatch: USPSTF weighs in on screening for language disorders or delays in kids Feb 03, 2024 podcast
<ѻý>Insulin Discontinuation Tension; FDA OKs Osteopenia Belt; Limited Mounjaro Supplyѻý> News and commentary from the endocrinology world Jan 30, 2024
<ѻý>Some 'Choosing Wisely' Recs Protect Older Folks From Low-Value Careѻý> Study looked at how three recommendations changed primary care decisions Jan 29, 2024
<ѻý>One Class of Antidiabetic Linked With Lower Kidney Stone Riskѻý> Study compared SGLT2 inhibitors with GLP-1 agonists and DPP-4 inhibitors Jan 29, 2024
<ѻý>Can the Eye Reveal Cardiac and Lung Disease -- Plus Much More?ѻý> Researchers link thinner retinal layers to higher risk of multiple diseases Jan 26, 2024
<ѻý>Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinismѻý> Daily treatment substantially reduced hypoglycemia over 13 weeks Jan 24, 2024